Form 4 holding
10%+ Owner
Taysha Gene Therapies, Inc.
- Security class
- Common Stock
- Shares / value
- 8,871,747
- Estimated value
- $14,460,948
- Report date
- 13 Jul 2023
- Price
- $1.63
- Ownership
- Direct
R.a. Session II - 10%+ Owner at Taysha Gene Therapies, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- TSHA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by R.a. Session II since 28 Aug 2025
Reported holdings for R.a. Session II in Taysha Gene Therapies, Inc.
Form 4 holding
10%+ Owner
Taysha Gene Therapies, Inc.
- Security class
- Common Stock
- Shares / value
- 141,090
- Estimated value
- $229,977
- Report date
- 12 Jul 2023
- Price
- $1.63
- Ownership
- Indirect
Transaction history for R.a. Session II in Taysha Gene Therapies, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.